The H9N2 subtype avian influenza virus(AIV)hemagglutinin(HA)protein is a major immunogen in which HA1 is a genetic variant and HA2 is relatively conserved.Identifying broad-spectrum antigen epitopes targeting HA1 is c...The H9N2 subtype avian influenza virus(AIV)hemagglutinin(HA)protein is a major immunogen in which HA1 is a genetic variant and HA2 is relatively conserved.Identifying broad-spectrum antigen epitopes targeting HA1 is crucial for vaccine design and detection.Based on the phylogenetic and serological analyses,we identified 2 antigenic groups and 3 representative viruses:A/chicken/Jiangsu/JY040218C/2019,A/pigeon/Jiangsu/JY020616/2019,and A/chicken/Jiangsu/WX090312/2018.An overlapping peptide library was synthesized using HA1 amino acid sequences of the viruses as templates.Through peptide scanning of the sera against different strains of H9N2 subtype AIV,we identified peptides from 4 regions(H9-2/3,H9-20/21,H9-26,and H9-29/30/31)that demonstrated broad-spectrum reactivity.Immunological assay results demonstrated that H9-21(^(219)RIFKPLIGPRPLVNGLMGRI^(239)),H9-26(^(269)SGESHGRILKTDLKMGSCTV^(289)),and H9-30(^(309)YAFGNCPKYI GVKSLKLAVG^(329))effectively induced antibody generation and conferred partial protective efficacy against the parent virus JY040218C.The results of lymphocyte proliferation and ELISpot assays indicated that peptides H9-15(^(159)MRWLTQKNNAYPTQDAQYTN^(179)),H9-22(^(229)PLVNGLMGRINYYWSVLKP G^(249)),and H9-23(^(239)NYYWSVLKPGQTLRIKSDGN^(259))could effectively stimulate the expression of interferon-gamma in peripheral blood lymphocytes of chickens immunized against different strains of H9N2 AIV.Collectively,5 novel cell epitopes H9-15,H9-22,H9-23,H9-26,and H9-30,including the best B cell epitope H9-26 and the best T cells epitope H9-22,were identified that could be targeted for vaccine design or detection approaches against H9N2 AIVs.展开更多
基金supported by the National Key Research and Development Program of China(2021YFD1800202)the National Natural Science Foundation of China(3237042 and 32172942)+3 种基金the“Jie Bang Gua Shuai”Project at Yangzhou University,China(YZUXK202316)the Agricultural Science and Technology Independent Innovation Fund of Jiangsu Province,China(SCX[22]3547)the Outstanding Technological Innovation Team of College and University at Jiangsu Province,China([2021]NO.1)a project funded by the Priority Academic Program Development of Jiangsu Higher Education,China(PAPD)。
文摘The H9N2 subtype avian influenza virus(AIV)hemagglutinin(HA)protein is a major immunogen in which HA1 is a genetic variant and HA2 is relatively conserved.Identifying broad-spectrum antigen epitopes targeting HA1 is crucial for vaccine design and detection.Based on the phylogenetic and serological analyses,we identified 2 antigenic groups and 3 representative viruses:A/chicken/Jiangsu/JY040218C/2019,A/pigeon/Jiangsu/JY020616/2019,and A/chicken/Jiangsu/WX090312/2018.An overlapping peptide library was synthesized using HA1 amino acid sequences of the viruses as templates.Through peptide scanning of the sera against different strains of H9N2 subtype AIV,we identified peptides from 4 regions(H9-2/3,H9-20/21,H9-26,and H9-29/30/31)that demonstrated broad-spectrum reactivity.Immunological assay results demonstrated that H9-21(^(219)RIFKPLIGPRPLVNGLMGRI^(239)),H9-26(^(269)SGESHGRILKTDLKMGSCTV^(289)),and H9-30(^(309)YAFGNCPKYI GVKSLKLAVG^(329))effectively induced antibody generation and conferred partial protective efficacy against the parent virus JY040218C.The results of lymphocyte proliferation and ELISpot assays indicated that peptides H9-15(^(159)MRWLTQKNNAYPTQDAQYTN^(179)),H9-22(^(229)PLVNGLMGRINYYWSVLKP G^(249)),and H9-23(^(239)NYYWSVLKPGQTLRIKSDGN^(259))could effectively stimulate the expression of interferon-gamma in peripheral blood lymphocytes of chickens immunized against different strains of H9N2 AIV.Collectively,5 novel cell epitopes H9-15,H9-22,H9-23,H9-26,and H9-30,including the best B cell epitope H9-26 and the best T cells epitope H9-22,were identified that could be targeted for vaccine design or detection approaches against H9N2 AIVs.